Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020
June 30, 2020 at 03:59 pm IST
Share
Remedent, Inc. announced earnings results for the full year ended March 31, 2020. For the full year, the company announced sales was USD 1.064 million compared to USD 1.603 million a year ago. Operating loss was USD 479,607 compared to USD 717,347 a year ago. Net loss was USD 858,222 compared to net income of USD 2.128 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to basic earnings per share from continuing operations of USD 0.11 a year ago.
Remedent, Inc. specializes in the research, development and manufacturing of oral care and cosmetic dentistry products. The Company designs, develops, manufactures and distributes its cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, Middle East and the United States. The Company's operating segment consists of dental products and oral hygiene products sold by Remedent Inc., Remedent N.V., and Biotech Dental Benelux N.V. The Company offers over-the-counter (OTC) tooth whitening products. It has three primary products: River 8, a prefabricated veneer; its custom-made GlamSmile Veneers and the SmileMe mirror. The Company has developed a range of prefabricated, ready-to-use veneers that the Company has branded as River8. The Company's product in the professional oral care and cosmetic dentistry is the GlamSmile veneer. The SmileMe Mirror enables the dentist to offer patients a complete Smile Consultation.
REMEDENT, INC. 